IgG and IgM antibodies to the refolded MOG1-125 extracellular domain in humans

Journal of Neuroimmunology

Volumn 233, Issue 1-2, 2011, Pages 216-220

  Gori, Francesca ^a   Mulinacci, Barbara ^a   Massai, Lara ^a   Avolio, Carlo ^b   Caragnano, Mariantonietta ^b   Peroni, Elisa ^a   Lori, Silvia ^c   Chelli, Mario ^a   Papini, Anna Maria ^a   Rovero, Paolo ^a   Lolli, Francesco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c Azienda Ospedaliero Universitaria di Careggi   (Italy)

Author keywords

Autoantibodies; Autoimmunity; Multiple sclerosis; Myelin oligodendrocyte glycoprotein

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[1-125]; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AFFINITY CHROMATOGRAPHY; ANTIBODY DETECTION; ARTICLE; BETA SHEET; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; CIRCULAR DICHROISM; CLINICAL ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MOLECULAR CLONING; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY;

ADULT; ANIMALS; EXTRACELLULAR SPACE; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RATS; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 79953318168     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.11.011     Document Type: Article

References (34)

1. Amor S., Groome N., Linington C., Morris M., Dornmair K., Gardinier M., Matthieu J., Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 1994, 153:4349-4356.
2. Angelucci F., Mirabella M., Frisullo G., Caggiula M., Tonali P.A., Batocchi A.P. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy. Dis. Markers 2005, 21:49-55.
3. Berger T., Rubner P., Schautzer F., Egg R., Ulmer H., Mayringer I., Dilitz E., Deisenhammer F., Reindl M. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N. Engl. J. Med. 2003, 349:139-145.
4. Bettadapura J., Menon K., Moritz S., Liu J., Bernard C. Expression, purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J. Neurochem. 1998, 70:1593-1599.
5. Brehm U., Piddlesden S., Gardinier M., Linington C. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 1999, 97:9-15.
6. Breithaupt C., Schubart A., Zander H., Skerra A., Huber R., Linington C., Jacob U. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proc. Natl Acad. Sci. USA 2003, 100:9446-9451.
7. Breithaupt C., Schafer B., Pellkofer H., Huber R., Linington C., Jacob U. Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents. J. Immunol. 2008, 181:1255-1263.
8. Brilot F., Dale R.C., Selter R.C., Grummel V., Kalluri S.R., Aslam M., Busch V., Zhou D., Cepok S., Hemmer B. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann. Neurol. 2009, 66:833-842.
9. Chan A., Decard B.F., Franke C., Grummel V., Zhou D., Schottstedt V., Toyka K.V., Hemmer B., Gold R. Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis. Mult. Scler. 2010, 16:1189-1192.
10. Clements C., Reid H., Beddoe T., Tynan F., Perugini M., Johns T., Bernard C., Rossjohn J. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc. Natl Acad. Sci. USA 2003, 100:11059-11064.
11. Gaertner S., de Graaf K., Greve B., Weissert R. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis. Neurology 2004, 63:2381-2383.
12. Greenfield N. Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 2006, 1:2876-2890.
13. Hughes L.E., Smith P.A., Bonell S., Natt R.S., Wilson C., Rashid T., Amor S., Thompson E.J., Croker J., Ebringer A. Cross-reactivity between related sequences found in Acinetobaeter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J. Neuroimmunol. 2003, 144:105-115.
14. Kelly S., Price N. The application of circular dichroism to studies of protein folding and unfolding. Biochim. Biophys. Acta 1997, 1338:161-185.
15. Kelly S., Jess T., Price N. How to study proteins by circular dichroism. Biochim. Biophys. Acta 2005, 1751:119-139.
16. Kennel De March A., De Bouwerie M., Kolopp-Sarda M., Faure G., Béné M., Bernard C. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. J. Neuroimmunol. 2003, 135:117-125.
17. Kuhle J., Lindberg R.L.P., Regeniter A., Mehling M., Hoffmann F., Reindl M., Berger T., Radue E.W., Leppert D., Kappos L. Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF. J. Neurol. 2007, 254:160-168.
18. Lalive P.H. Auto antibodies in inflammatory demyelinating diseases of the central nervous system. Swiss Med. Wkly 2008, 138:692-707.
19. Lalive P.H., Menge T., Delarasse C., Della Gaspera B., Pham-Dinh D., Villoslada P., von Budingen H.C., Genain C.P. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc. Natl Acad. Sci. USA 2006, 103:2280-2285.
20. Lampasona V., Franciotta D., Furlan R., Zanaboni S., Fazio R., Bonifacio E., Comi G., Martino G. Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology 2004, 62:2092-2094.
21. Liñares D., Echevarria I., Mañá P. Single-step purification and refolding of recombinant mouse and human myelin oligodendrocyte glycoprotein and induction of EAE in mice. Protein Expr. Purif. 2004, 34:249-256.
22. Mantegazza R., Cristaldini P., Bernasconi P., Baggi F., Pedotti R., Piccini I., Mascoli N., Mantia L.L., Antozzi C., Simoncini O., Cornelio F., Milanese C. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association. Int. Immunol. 2004, 16:559-565.
23. McDonald W.I., Noseworthy J.H. Multiple sclerosis 2 2003, Butterworth-Heinemann, Boston, pp. xv, 377 p.
24. McLaughlin K.A., Chitnis T., Newcombe J., Franz B., Kennedy J., McArdel S., Kuhle J., Kappos L., Rostasy K., Pohl D., Gagne D., Ness J.M., Tenembaum S., O'Connor K.C., Viglietta V., Wong S.J., Tavakoli N.P., de Seze J., Idrissova Z., Khoury S.J., Bar-Or A., Hafler D.A., Banwell B., Wucherpfennig K.W. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J. Immunol. 2009, 183:4067-4076.
25. Menge T., von Budingen H.C., Lalive P.H., Genain C.P. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA. Eur. J. Immunol. 2007, 37:3229-3239.
26. O'Connor K.C., Appel H., Bregoli L., Call M.E., Catz I., Chan J.A., Moore N.H., Warren K.G., Wong S.J., Hafler D.A., Wucherpfennig K.W. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J. Immunol. 2005, 175:1974-1982.
27. Pittock S.J., Reindl M., Achenboch S., Berger T., Bruck W., Konig F., Morales Y., Lassmann H., Bryants S., Moore S.B., Keegan B.M., Lucchinetti C.F. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult. Scler. 2007, 13:7-16.
28. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
29. Reindl M., Linington C., Brehm U., Egg R., Dilitz E., Deisenhammer F., Poewe W., Berger T. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 1999, 122:2047-2056.
30. Selter R.C., Brilot F., Grummel V., Kraus V., Cepok S., Dale R.C., Hemmer B. Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases. Neurology 2010, 74:1711-1715.
31. von Budingen H.C., Hauser S.L., Ouallet J.C., Tanuma N., Menge T., Genain C.P. Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur. J. Immunol. 2004, 34:2072-2083.
32. Wang H., Munger K.L., Reindl M., O'Reilly E.J., Levin L.I., Berger T., Ascherio A. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology 2008, 71:1142-1146.
33. Xiao B., Linington C., Link H. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 1991, 31:91-96.
34. Zhou D., Srivastava R., Nessler S., Grummel V., Sommer N., Bruck W., Hartung H.P., Stadelmann C., Hemmer B. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl Acad. Sci. USA 2006, 103:19057-19062.